Javascript seems to be disabled. This will break some core site features. Please enable javascript or revisit this site from another device.
25 October
SESSION I
Cancer and the Immune system
SESSION II
Transformative Oncology
SESSION III
Personalized Healthcare – What is next?
Preliminary Program
WELCOME
| 08.15-08.45 | Registration |
| 08.45-09.00 |
Prof. Carl Borrebaeck - Welcome |
SESSION I – Cancer and the Immune system
| 09.00 - 09.40 | Opening Keynote: Prof. MD Gordon Mills Delivering on the promise of personalized medicine |
| 09.45 – 10.15 | Networking and Coffee |
| 10.15 - 10.40 | Seth Coffelt, PhD Immune cells under the influence of metastatic cancer |
| 10.45 - 11.10 | Prof. Karin Leandersson Tumor associated macrophage plasticity and interplay with tumor and lymph nodes in breast cancer |
SESSION II – Transformative Oncology
| 11.20 – 12.00 | Keynote: Dr. Imran Hague The Freenome, information and early disease detection |
| 12:05 – 12:30 | Dr. Erica Sloan, PhD Does stress impact cancer? Defining mechanisms and evaluating strategies for intervention? |
| 12.30 – 14.00 | Networking and Lunch |
SESSION III – Personalized Healthcare – What is next?
| 14.10 – 14.35 | Prof. Aron Popovtzer, MD Mutation profiling for better treatment options |
| 14.40 – 15.05 | Prof. Björn Örnfelt Single cell assays for improved immunotherapy |
| 15.10 – 15.40 | Networking and Coffee |
| 15.40 – 15:05 | Dr. Paul Morten Mau-Sørensen, MD, PhD Innovative trial design in an era of personalized cancer therapy |
| 16.10 – 16.50 | Keynote: Prof. Julian Marchesi Human Microbiomes and cancer |
| 16.50 |
Concluding remarks |
| 17.00 | Networking and Buffé |